BME100 s2015:Group12 12pmL1: Difference between revisions
Line 82: | Line 82: | ||
Possible Controls: | Possible Controls: | ||
*The team will question the subject on why he | *The team will question the subject on why he or she wants to end the experiment, and would try to convince them to see the experiment through completion, as it is meant for the greater good of the public. If however the subject is resistant to encouragement, the subject will be discharged from the experiment, and random selection will be needed to fill the vacancy. | ||
*It is one of the team’s best interests to ensure the subject’s personal views are not infringed upon for the duration of the experiment. The team will disclose any information or conflicts that the subject feels needs to be addressed before entering the laboratory environment. They have the right to opt out of the experiment at any time. | *It is one of the team’s best interests to ensure the subject’s personal views are not infringed upon for the duration of the experiment. The team will disclose any information or conflicts that the subject feels needs to be addressed before entering the laboratory environment. They have the right to opt out of the experiment at any time. |
Revision as of 13:57, 25 January 2015
BME 100 Spring 2015 | Home People Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3 Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6 Course Logistics For Instructors Photos Wiki Editing Help | |||||
OUR TEAMLAB 1 WRITE-UPWARNING: All material presented here is highly suspectible to change by the write-up's authors. Final draft will be complete by Tuesday, 11:59 P.M. Independent and Dependent VariablesIndependent Variable: Lipopolysacchride (LPS) would be the variable the research team changes, because according to the ELISA data analysis provided, the levels of inflammotin in the blood sample analyzed were affected by a determined amount of the drug, 10 mg. The team will be able to deduce how inflammotin levels interact with a certain dosage of LPS by manipulating this variable. Dependent Variable: Inflammotin is the protein responsible for inflammation and is the central part of the experiment the team will conduct. This variable will fluctuate based on the dosage of LPS the research team will administrator to the test groups. Experimental DesignGroups
Age Age limit is between 60 to 70 years of age. The research team believes this is the prime demographic of elderly individuals whose personal health is adequate. These individuals are less likely to succumb to biological factors such as cell decay or organ failure, often from 71 years of age and older. Such issues may complicate the experiment.
10 subjects for each group, totaling 5 groups.
Subject Selection
Sources of Error and Bias
|